Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning.

[1]  R. Bolli.  The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an overview , 1996, Basic Research in Cardiology.

[2]  E. Clementi,et al.  Activation of endothelial nitric-oxide synthase by tumor necrosis factor-alpha: a novel pathway involving sequential activation of neutral sphingomyelinase, phosphatidylinositol-3' kinase, and Akt. , 2003, Molecular pharmacology.

[3]  T. Peng,et al.  Endothelial Nitric-oxide Synthase Enhances Lipopolysaccharide-stimulated Tumor Necrosis Factor-α Expression via cAMP-mediated p38 MAPK Pathway in Cardiomyocytes* , 2003, The Journal of Biological Chemistry.

[4]  R. Bolli,et al.  Aldose Reductase Is an Obligatory Mediator of the Late Phase of Ischemic Preconditioning , 2002, Circulation research.

[5]  R. Bolli,et al.  Role of Cyclic Guanosine Monophosphate in Late Preconditioning in Conscious Rabbits , 2002, Circulation.

[6]  M. Seishima,et al.  Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha. , 2002, Journal of the American College of Cardiology.

[7]  M. Karin,et al.  Signal transduction by tumor necrosis factor and its relatives. , 2001, Trends in cell biology.

[8]  R. Bolli,et al.  An essential role of the JAK-STAT pathway in ischemic preconditioning , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Karin,et al.  AP-1 in cell proliferation and survival , 2001, Oncogene.

[10]  R. Bolli.  The Late Phase of Preconditioning , 2000, Circulation research.

[11]  R. Bolli,et al.  Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. , 2000, American journal of physiology. Heart and circulatory physiology.

[12]  M. Hori,et al.  The involvement of cytokines in the second window of ischaemic preconditioning , 2000, British journal of pharmacology.

[13]  D. Mann,et al.  Nitric Oxide Provokes Tumor Necrosis Factor-&agr; Expression in Adult Feline Myocardium Through a cGMP-Dependent Pathway , 2000, Circulation.

[14]  R. Bolli,et al.  Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G Baumgarten,et al.  Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[17]  R. Bolli,et al.  Nitroglycerin induces late preconditioning against myocardial stunning via a PKC-dependent pathway. , 1999, American journal of physiology. Heart and circulatory physiology.

[18]  P. Ping,et al.  The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Bolli,et al.  Nuclear Factor- (cid:107) B Plays an Essential Role in the Late Phase of Ischemic Preconditioning in Conscious Rabbits , 2022 .

[20]  D. Mann,et al.  Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. , 1999, Circulation.

[21]  R. Bolli,et al.  Demonstration of an early and a late phase of ischemic preconditioning in mice. , 1998, American journal of physiology. Heart and circulatory physiology.

[22]  P. Ping,et al.  The nitric oxide hypothesis of late preconditioning , 1998, Basic Research in Cardiology.

[23]  A. Harken,et al.  Human Myocardial Tissue TNFαExpression Following Acute Global IschemiaIn Vivo , 1998 .

[24]  M. Lindsey,et al.  Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. , 1998, Circulation.

[25]  B. A. French,et al.  Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. , 1998, Circulation research.

[26]  Yulan He,et al.  Transcriptional induction of cyclooxygenase‐2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: Co‐stimulation of AP‐1 and CRE nuclear binding proteins , 1998, Journal of cellular biochemistry.

[27]  R. Bolli,et al.  Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. , 1997, American journal of physiology. Heart and circulatory physiology.

[28]  J. Gurevitch,et al.  Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. , 1997, Journal of the American College of Cardiology.

[29]  P. Ping,et al.  Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. , 1997, Circulation research.

[30]  R. Bolli,et al.  Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. , 1997, Circulation research.

[31]  G. Freeman,et al.  Induction of nuclear factor κB and activation protein 1 in postischemic myocardium , 1997, FEBS letters.

[32]  D. Zechner,et al.  Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. , 1996, The Journal of clinical investigation.

[33]  M. Díaz-Guerra,et al.  Evidence for Common Mechanisms in the Transcriptional Control of Type II Nitric Oxide Synthase in Isolated Hepatocytes , 1996, The Journal of Biological Chemistry.

[34]  M. Barna,et al.  Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection. , 1996, Virology.

[35]  E. Claassen,et al.  In vivo expression of interleukin-1 beta (IL-1 beta), IL-2, IL-4, IL-6, tumour necrosis factor-alpha and interferon-gamma in the fetal murine thymus. , 1996, Immunology.

[36]  D. Mann,et al.  Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart , 1996 .

[37]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[38]  Kei Yamamoto,et al.  Transcriptional Roles of Nuclear Factor B and Nuclear Factor-Interleukin-6 in the Tumor Necrosis Factor -Dependent Induction of Cyclooxygenase-2 in MC3T3-E1 Cells (*) , 1995, The Journal of Biological Chemistry.

[39]  M. Karin.  The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases (*) , 1995, The Journal of Biological Chemistry.

[40]  S. Gross,et al.  Nitric oxide: pathophysiological mechanisms. , 1995, Annual review of physiology.

[41]  C. Lowenstein,et al.  Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. , 1994, The Journal of biological chemistry.

[42]  J. Satriano,et al.  Activation and attenuation of transcription factor NF-kB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3':5'-cyclic monophosphate. Evidence for involvement of reactive oxygen species. , 1994, The Journal of clinical investigation.

[43]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[44]  C. Nathan,et al.  Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide , 1993, The Journal of experimental medicine.

[45]  M. Hori,et al.  Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. , 1993, Circulation research.

[46]  D. Levine,et al.  Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. , 1993, Journal of immunology.

[47]  W. Schaper,et al.  Proto-oncogene expression in porcine myocardium subjected to ischemia and reperfusion. , 1992, Circulation research.

[48]  F. Pagani,et al.  Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. , 1992, The Journal of clinical investigation.

[49]  G. Wong,et al.  Tumor necrosis factor-α pretreatment is protective in a rat model of myocardial ischemia-reperfusion injury , 1992 .

[50]  M. Karin,et al.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. , 1991, Biochimica et biophysica acta.

[51]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[52]  B. Freeman,et al.  Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. , 1991, The Journal of biological chemistry.

[53]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Michael E. Greenberg,et al.  c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities , 1988, Cell.

[55]  R. Tjian,et al.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements , 1987, Cell.

[56]  David Baltimore,et al.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.

[57]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[58]  J. Fleiss,et al.  Some Statistical Methods Useful in Circulation Research , 1980, Circulation research.